Table 1.
Cohort characteristics.
| Age | |
| Median | 55 |
| Mean (SD) | 56.6 (13.1) |
| Missing | 1 |
| IQR | 35.4 |
| Stage | |
| I | 115 |
| II | 46 |
| III | 27 |
| IV | 10 |
| Missing | 12 |
| Grade | |
| 1 | 107 |
| 2 | 60 |
| 3 | 37 |
| Missing | 6 |
| OS follow-up | |
| Median | 5.1 |
| Mean (SD) | 6.04 (4.32) |
| DSS follow-up | |
| Median | 5.14 |
| Mean (SD) | 6.07 (4.31) |
| Missing | 3 |
| PFS follow-up | |
| Median | 4.91 |
| Mean (SD) | 5.88 (4.41) |
| Missing | 10 |
| Residual disease | |
| Any | 17 |
| None | 188 |
| Missing | 5 |
| Neoadjuvant therapy | |
| No | 72 |
| Yes | 1 |
| Missing | 137 |
| Postsurgical chemotherapy | |
| No | 63 |
| Yes | 132 |
| Missing | 15 |
| Total | |
| n | 210 |
Abbreviation: IQR, interquartile range.